Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort

Documenti analoghi

• Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
  di: Caiyu Wang, et al.
  Pubblicazione: (2025)
• Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
  di: Daniel Muñoz-Barba, et al.
  Pubblicazione: (2025)
• Therapeutic Response of Alopecia Areata‐Associated Nail Changes to Baricitinib
  di: Ashley Wittmer, et al.
  Pubblicazione: (2024)
• Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
  di: Athanasios J. Stefanis, et al.
  Pubblicazione: (2024)
• Safety Profile of Baricitinib in Patients With Severe Alopecia Areata: A Prospective Study
  di: Isotta Giunipero di Corteranzo, et al.
  Pubblicazione: (2025)